Your browser doesn't support javascript.
loading
Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system.
Renovanz, Mirjam; Kurz, Sylvia C; Rieger, Johannes; Walter, Bianca; Becker, Hannes; Hille, Hanni; Bombach, Paula; Rieger, David; Grosse, Lucia; Häusser, Lara; Skardelly, Marco; Merk, Daniel J; Paulsen, Frank; Hoffmann, Elgin; Gani, Cihan; Neumann, Manuela; Beschorner, Rudi; Rieß, Olaf; Roggia, Cristiana; Schroeder, Christopher; Ossowski, Stephan; Armeanu-Ebinger, Sorin; Gschwind, Axel; Biskup, Saskia; Schulze, Martin; Fend, Falko; Singer, Stephan; Zender, Lars; Lengerke, Claudia; Brucker, Sara Yvonne; Engler, Tobias; Forschner, Andrea; Stenzl, Arnulf; Kohlbacher, Oliver; Nahnsen, Sven; Gabernet, Gisela; Fillinger, Sven; Bender, Benjamin; Ernemann, Ulrike; Öner, Öznur; Beha, Janina; Malek, Holly Sundberg; Möller, Yvonne; Ruhm, Kristina; Tatagiba, Marcos; Schittenhelm, Jens; Bitzer, Michael; Malek, Nisar; Zips, Daniel; Tabatabai, Ghazaleh.
Afiliação
  • Renovanz M; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.
  • Kurz SC; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.
  • Rieger J; Department of Neurosurgery, Eberhard Karls University Tübingen, Germany.
  • Walter B; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.
  • Becker H; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.
  • Hille H; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.
  • Bombach P; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.
  • Rieger D; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.
  • Grosse L; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.
  • Häusser L; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.
  • Skardelly M; Department of Neurosurgery, Eberhard Karls University Tübingen, Germany.
  • Merk DJ; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.
  • Paulsen F; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.
  • Hoffmann E; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.
  • Gani C; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.
  • Neumann M; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.
  • Beschorner R; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.
  • Rieß O; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.
  • Roggia C; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.
  • Schroeder C; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.
  • Ossowski S; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany.
  • Armeanu-Ebinger S; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.
  • Gschwind A; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.
  • Biskup S; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.
  • Schulze M; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.
  • Fend F; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.
  • Singer S; Department of Radiation Oncology, Eberhard Karls University Tübingen, Germany.
  • Zender L; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.
  • Lengerke C; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.
  • Brucker SY; Department of Radiation Oncology, Eberhard Karls University Tübingen, Germany.
  • Engler T; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.
  • Forschner A; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.
  • Stenzl A; Department of Radiation Oncology, Eberhard Karls University Tübingen, Germany.
  • Kohlbacher O; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany.
  • Nahnsen S; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.
  • Gabernet G; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.
  • Fillinger S; Institute of Pathology and Neuropathology, Department of Neuropathology, Eberhard Karls University Tübingen, Germany.
  • Bender B; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany.
  • Ernemann U; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.
  • Öner Ö; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.
  • Beha J; Institute of Pathology and Neuropathology, Department of Neuropathology, Eberhard Karls University Tübingen, Germany.
  • Malek HS; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany.
  • Möller Y; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.
  • Ruhm K; Institute of Medical Genetics and Applied Genomics, Eberhard Karls University Tübingen, Germany.
  • Tatagiba M; Cluster of Excellence (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University of Tübingen, Germany.
  • Schittenhelm J; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany.
  • Bitzer M; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.
  • Malek N; Institute of Medical Genetics and Applied Genomics, Eberhard Karls University Tübingen, Germany.
  • Zips D; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.
  • Tabatabai G; Institute of Medical Genetics and Applied Genomics, Eberhard Karls University Tübingen, Germany.
Neurooncol Adv ; 5(1): vdad012, 2023.
Article em En | MEDLINE | ID: mdl-36915613
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies Idioma: En Revista: Neurooncol Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies Idioma: En Revista: Neurooncol Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha